W. Lever and . Pemphigus, PEMPHIGUS, Medicine, vol.32, issue.1, pp.1-123, 1953.
DOI : 10.1097/00005792-195302000-00001

E. Schmidt and D. Zillikens, Pemphigoid diseases, The Lancet, vol.381, issue.9863, pp.320-352, 2013.
DOI : 10.1016/S0140-6736(12)61140-4

P. Bernard and F. Antonicelli, Bullous Pemphigoid: A Review of its Diagnosis, Associations and Treatment, American Journal of Clinical Dermatology, vol.231, issue.2, pp.513-541, 2017.
DOI : 10.1159/000381143

K. Amber, D. Murrell, E. Schmidt, P. Joly, and L. Borradori, Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management, Clinical Reviews in Allergy & Immunology, vol.138, issue.365???372, pp.26-51, 2018.
DOI : 10.1046/j.1365-2133.1998.02167.x

L. Diaz, H. Ratrie, W. Saunders, S. Futamura, H. Squiquera et al., Isolation of a human epidermal cDNA corresponding to the 180-kD autoantigen recognized by bullous pemphigoid and herpes gestationis sera. Immunolocalization of this protein to the hemidesmosome., Journal of Clinical Investigation, vol.86, issue.4, pp.1088-9410, 1172.
DOI : 10.1172/JCI114812

URL : http://www.jci.org/articles/view/114812/files/pdf

R. Labib, G. Anhalt, H. Patel, D. Mutasim, and L. Diaz, Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting, J Immunol, vol.136, pp.1231-1236, 1986.

J. Stanley, Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases., Journal of Clinical Investigation, vol.83, issue.5, pp.1443-1451, 1989.
DOI : 10.1172/JCI114036

URL : http://www.jci.org/articles/view/114036/files/pdf

S. Goletz, D. Zillikens, and E. Schmidt, Structural proteins of the dermal-epidermal junction targeted by autoantibodies in pemphigoid diseases, Experimental Dermatology, vol.228, issue.Pt 17, pp.1154-62, 2017.
DOI : 10.1111/j.0022-202X.2005.23702.x

Y. Liu, L. Li, and Y. Xia, BP180 Is Critical in the Autoimmunity of Bullous Pemphigoid, Frontiers in Immunology, vol.35, 2017.
DOI : 10.1007/s10067-016-3354-2

G. Giudice, D. Emery, B. Zelickson, G. Anhalt, Z. Liu et al., Bullous pemphigoid and herpes gestationis autoantibodies recognize a common noncollagenous site on the BP180 ectodomain, J Immunol, vol.151, pp.5742-50, 1993.
DOI : 10.1016/0923-1811(93)90940-q

J. Perriard, F. Jaunin, B. Favre, L. Büdinger, M. Hertl et al., IgG Autoantibodies from Bullous Pemphigoid (BP) Patients Bind Antigenic Sites on Both the Extracellular and the Intracellular Domains of the BP Antigen 180, Journal of Investigative Dermatology, vol.112, issue.2, pp.141-148, 1999.
DOI : 10.1046/j.1523-1747.1999.00497.x

S. Hofmann, S. Thoma-uszynski, T. Hunziker, P. Bernard, C. Koebnick et al., Severity and Phenotype of Bullous Pemphigoid Relate to Autoantibody Profile Against the NH2- and COOH-Terminal Regions of the BP180 Ectodomain, Journal of Investigative Dermatology, vol.119, issue.5, pp.1065-73, 2002.
DOI : 10.1046/j.1523-1747.2002.19529.x

D. Zenzo, G. Thoma-uszynski, S. Fontao, L. Calabresi, V. Hofmann et al., Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid, Clinical Immunology, vol.128, issue.3, pp.415-441, 2008.
DOI : 10.1016/j.clim.2008.04.012

A. Roussel, J. Benichou, Z. Randriamanantany, D. Gilbert, K. Drenovska et al., Enzyme-linked immunosorbent assay for the combination of Frontiers in Immunology | www.frontiersin, Article, vol.9, issue.570, 2018.

J. Charneux, J. Lorin, F. Vitry, F. Antonicelli, Z. Reguiai et al., Usefulness of BP230 and BP180-NC16a Enzyme-Linked Immunosorbent Assays in the Initial Diagnosis of Bullous Pemphigoid, Archives of Dermatology, vol.147, issue.3, pp.286-91, 2011.
DOI : 10.1001/archdermatol.2011.23

URL : https://hal.archives-ouvertes.fr/hal-00584055

F. Fichel, C. Barbe, P. Joly, C. Bedane, P. Vabres et al., Clinical and Immunologic Factors Associated With Bullous Pemphigoid Relapse During the First Year of Treatment, JAMA Dermatology, vol.150, issue.1, pp.25-33, 2014.
DOI : 10.1001/jamadermatol.2013.5757

URL : http://archderm.jamanetwork.com/data/journals/derm/929683/doi130040.pdf

C. Nakatani, T. Muramatsu, and T. Shirai, Immunoreactivity of bullous pemphigoid (BP) autoantibodies against the NC16A and C-terminal domains of the 180???kDa BP antigen (BP180): immunoblot analysis and enzyme-linked immunosorbent assay using BP180 recombinant proteins, British Journal of Dermatology, vol.109, issue.3, pp.365-70, 1998.
DOI : 10.1007/s004030050093

M. Chen, G. Kim, L. Prakash, and D. Woodley, Epidermolysis bullosa acquisita: Autoimmunity to anchoring fibril collagen, Autoimmunity, vol.83, issue.1, pp.91-101, 2011.
DOI : 10.1111/1523-1747.ep12261694

URL : http://europepmc.org/articles/pmc3411315?pdf=render

J. Kim, Y. Kim, and S. Kim, Epidermolysis Bullosa Acquisita: A Retrospective Clinical Analysis of 30 Cases, Acta Dermato Venereologica, vol.91, issue.3, pp.307-319, 2011.
DOI : 10.2340/00015555-1065

URL : https://www.medicaljournals.se/acta/content_files/download.php?doi=10.2340/00015555-1065

R. Ludwig, Clinical Presentation, Pathogenesis, Diagnosis, and Treatment of Epidermolysis Bullosa Acquisita, ISRN Dermatology, vol.89, issue.5, p.812029, 2013.
DOI : 10.1016/j.jaad.2006.05.057

URL : http://downloads.hindawi.com/archive/2013/812029.pdf

K. Bieber, H. Koga, and W. Nishie, In vitro and in vivo models to investigate the pathomechanisms and novel treatments for pemphigoid diseases, Experimental Dermatology, vol.131, issue.12, pp.1163-70, 2017.
DOI : 10.1038/jid.2010.248

URL : http://onlinelibrary.wiley.com/doi/10.1111/exd.13415/pdf

R. Ludwig, K. Vanhoorelbeke, F. Leypoldt, Z. Kaya, K. Bieber et al., Mechanisms of Autoantibody-Induced Pathology, Frontiers in Immunology, vol.34, 2017.
DOI : 10.1016/j.autrev.2012.07.005

URL : http://journal.frontiersin.org/article/10.3389/fimmu.2017.00603/pdf

Z. Liu, W. Sui, M. Zhao, Z. Li, N. Li et al., Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model, Journal of Autoimmunity, vol.31, issue.4, pp.331-339, 2008.
DOI : 10.1016/j.jaut.2008.08.009

URL : http://europepmc.org/articles/pmc2642586?pdf=render

D. Zillikens, P. Rose, S. Balding, Z. Liu, M. Olague-marchan et al., Tight Clustering of Extracellular BP180 Epitopes Recognized by Bullous Pemphigoid Autoantibodies, Journal of Investigative Dermatology, vol.109, issue.4, pp.573-582, 1997.
DOI : 10.1111/1523-1747.ep12337492

URL : https://doi.org/10.1111/1523-1747.ep12337492

E. Schmidt, K. Obe, E. Bröcker, and D. Zillikens, Serum Levels of Autoantibodies to BP180 Correlate With Disease Activity in Patients With Bullous Pemphigoid, Archives of Dermatology, vol.136, issue.2, 2000.
DOI : 10.1001/archderm.136.2.174

URL : http://archderm.jamanetwork.com/data/journals/derm/4635/dst9032.pdf

C. Haase, L. Büdinger, L. Borradori, C. Yee, H. Merk et al., Detection of IgG autoantibodies in the sera of patients with bullous and gestational pemphigoid: ELISA studies utilizing a baculovirus-encoded form of bullous pemphigoid antigen 2, J Invest Dermatol, vol.110, pp.282-288, 1998.

P. Bernard, Z. Reguiai, E. Tancrède-bohin, N. Cordel, P. Plantin et al., Risk Factors for Relapse in Patients With Bullous Pemphigoid in Clinical Remission, Archives of Dermatology, vol.145, issue.5, pp.537-4253, 2009.
DOI : 10.1001/archdermatol.2009.53

URL : https://hal.archives-ouvertes.fr/hal-00396992

P. Joly, J. Roujeau, J. Benichou, E. Delaporte, D. Incan et al., A Comparison of Two Regimens of Topical Corticosteroids in the Treatment of Patients with Bullous Pemphigoid: A Multicenter Randomized Study, Journal of Investigative Dermatology, vol.129, issue.7, pp.1681-7412, 2008.
DOI : 10.1038/jid.2008.412

URL : https://hal.archives-ouvertes.fr/hal-00396990

P. Joly, J. Roujeau, J. Benichou, C. Picard, B. Dreno et al., A Comparison of Oral and Topical Corticosteroids in Patients with Bullous Pemphigoid, New England Journal of Medicine, vol.346, issue.5, pp.321-328, 2002.
DOI : 10.1056/NEJMoa011592

K. Kyriakis, V. Paparizos, D. Panteleos, and A. Tosca, Re-evaluation of the natural course of bullous pemphigoid. A prospective study, International Journal of Dermatology, vol.282, issue.715, 1999.
DOI : 10.1007/BF00371640

A. Brulefert, L. Jan, S. Plée, J. Durlach, A. Bernard et al., Variation of the epidermal expression of glucocorticoid receptor-beta as potential predictive marker of bullous pemphigoid outcome, Experimental Dermatology, vol.139, issue.12, pp.1261-1267, 2017.
DOI : 10.1016/j.jaci.2016.08.012

S. Cai, Y. Lim, W. Li, J. Allen, S. Chua et al., Anti-BP180 NC16A IgG titres as an indicator of disease activity and outcome in Asian patients with bullous pemphigoid, Ann Acad Med Singapore, vol.44, pp.119-145, 2015.

L. Vaillant, P. Bernard, P. Joly, C. Prost, B. Labeille et al., Evaluation of Clinical Criteria for Diagnosis of Bullous Pemphigoid, Archives of Dermatology, vol.134, issue.9, pp.1075-80, 1998.
DOI : 10.1001/archderm.134.9.1075

URL : http://archderm.jamanetwork.com/data/journals/derm/4618/dst8011.pdf

D. Murrell, B. Daniel, P. Joly, L. Borradori, M. Amagai et al., Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts, Journal of the American Academy of Dermatology, vol.66, issue.3, pp.479-85, 2012.
DOI : 10.1016/j.jaad.2011.06.032

URL : http://europepmc.org/articles/pmc3883429?pdf=render

A. Marzano, E. Cozzani, D. Fanoni, D. Pità, O. Vassallo et al., Diagnosis and disease severity assessment of epidermolysis bullosa acquisita by ELISA for anti-type VII collagen autoantibodies: an Italian multicentre study, British Journal of Dermatology, vol.62, issue.1, pp.80-84, 2013.
DOI : 10.1111/j.1468-3083.2012.04617.x

M. Kobayashi, M. Amagai, K. Kuroda-kinoshita, T. Hashimoto, Y. Shirakata et al., BP180 ELISA using bacterial recombinant NC16a protein as a diagnostic and monitoring tool for bullous pemphigoid, Journal of Dermatological Science, vol.30, issue.3, pp.224-256, 2002.
DOI : 10.1016/S0923-1811(02)00109-3

M. Yoshida, T. Hamada, M. Amagai, K. Hashimoto, R. Uehara et al., Enzyme-linked immunosorbent assay using bacterial recombinant proteins of human BP230 as a diagnostic tool for bullous pemphigoid, Journal of Dermatological Science, vol.41, issue.1, 2006.
DOI : 10.1016/j.jdermsci.2005.11.002

E. Licarete, S. Ganz, M. Recknagel, D. Zenzo, G. Hashimoto et al., Prevalence of collagen VII-specific autoantibodies in patients with autoimmune and inflammatory diseases, BMC Immunology, vol.13, issue.1, pp.16-26, 2012.
DOI : 10.1186/1471-2172-13-16

URL : https://bmcimmunol.biomedcentral.com/track/pdf/10.1186/1471-2172-13-16?site=bmcimmunol.biomedcentral.com

V. Seta, F. Aucouturier, J. Bonnefoy, L. Roux-villet, C. Pendaries et al., Comparison of 3 type VII collagen (C7) assays for serologic diagnosis of epidermolysis bullosa acquisita (EBA), Journal of the American Academy of Dermatology, vol.74, issue.6, pp.1166-72, 2016.
DOI : 10.1016/j.jaad.2016.01.005

T. Schmidt, M. Hoch, L. Jad, S. Solimani, F. et al., Serological diagnostics in the detection of IgG autoantibodies against human collagen VII in epidermolysis bullosa acquisita: a multicentre analysis, British Journal of Dermatology, vol.77, issue.6, pp.1683-92, 2017.
DOI : 10.1046/j.1365-2133.2002.04863.x

A. Clapé, C. Muller, G. Gatouillat, L. Jan, S. Barbe et al., Mucosal Involvement in Bullous Pemphigoid Is Mostly Associated with Disease Severity and to Absence of Anti-BP230 Autoantibody, Frontiers in Immunology, vol.26, p.479, 2018.
DOI : 10.1111/exd.13446

D. Zenzo, G. Thoma-uszynski, S. Calabresi, V. Fontao, L. Hofmann et al., Demonstration of Epitope-Spreading Phenomena in Bullous Pemphigoid: Results of a Prospective Multicenter Study, Journal of Investigative Dermatology, vol.131, issue.11, pp.2271-80, 2011.
DOI : 10.1038/jid.2011.180

L. Chan, C. Vanderlugt, T. Hashimoto, T. Nishikawa, J. Zone et al., Epitope Spreading: Lessons From Autoimmune Skin Diseases, Journal of Investigative Dermatology, vol.110, issue.2, 1998.
DOI : 10.1046/j.1523-1747.1998.00107.x

URL : https://doi.org/10.1046/j.1523-1747.1998.00107.x

J. Plée, L. Jan, S. Giustiniani, J. Barbe, C. Joly et al., Integrating longitudinal serum IL-17 and IL-23 follow-up, along with autoantibodies variation, contributes to predict bullous pemphigoid outcome, Scientific Reports, vol.134, issue.1, 2015.
DOI : 10.1001/archderm.134.9.1075

M. Riani, L. Jan, S. Plée, J. Durlach, A. et al., Bullous pemphigoid outcome is associated with CXCL10-induced matrix metalloproteinase 9 secretion from monocytes and neutrophils but not lymphocytes, Journal of Allergy and Clinical Immunology, vol.139, issue.3, pp.863-72, 2016.
DOI : 10.1016/j.jaci.2016.08.012

URL : https://hal.archives-ouvertes.fr/hal-01754072

D. Giusti, G. Gatouillat, L. Jan, S. Plée, J. Bernard et al., Eosinophil Cationic Protein (ECP), a predictive marker of bullous pemphigoid severity and outcome, Scientific Reports, vol.138, issue.1, p.4833, 2017.
DOI : 10.1016/j.annder.2011.01.009

URL : https://www.nature.com/articles/s41598-017-04687-5.pdf

D. Giusti, L. Jan, S. Gatouillat, G. Bernard, P. Pham et al., Biomarkers related to bullous pemphigoid activity and outcome, Experimental Dermatology, vol.97, issue.Pt 3, pp.1240-1247, 2017.
DOI : 10.1016/j.cyto.2017.05.014

URL : http://onlinelibrary.wiley.com/doi/10.1111/exd.13459/pdf

X. Zhou, J. Tang, H. Cao, H. Fan, and B. Li, Tissue resident regulatory T cells: novel therapeutic targets for human disease, Cellular & Molecular Immunology, vol.480, issue.5, pp.543-52, 2015.
DOI : 10.1038/nature09114

URL : http://www.nature.com/cmi/journal/v12/n5/pdf/cmi201523a.pdf

T. Gambichler, A. Tsitlakidon, M. Skrygan, S. Höxtermann, L. Susok et al., T regulatory cells and other lymphocyte subsets in patients with bullous pemphigoid, Clinical and Experimental Dermatology, vol.119, issue.6, pp.632-639, 2017.
DOI : 10.1046/j.1523-1747.2002.19529.x

E. Antiga, P. Quaglino, W. Volpi, I. Pierini, D. Bianco et al., Regulatory T cells in skin lesions and blood of patients with bullous pemphigoid, Journal of the European Academy of Dermatology and Venereology, vol.10, issue.2, pp.222-252, 2014.
DOI : 10.1016/j.autrev.2011.05.004

URL : https://iris.unito.it/bitstream/2318/142764/4/142764_4aperto.pdf

K. Bieber, S. Sun, M. Witte, A. Kasprick, F. Beltsiou et al., Regulatory T Cells Suppress Inflammation and Blistering in Pemphigoid Diseases, Frontiers in Immunology, vol.10, 2017.
DOI : 10.1038/nrrheum.2014.105

URL : https://www.frontiersin.org/articles/10.3389/fimmu.2017.01628/pdf

T. Schmidt, C. Sitaru, K. Amber, and M. Hertl, BP180- and BP230-specific IgG autoantibodies in pruritic disorders of the elderly: a preclinical stage of bullous pemphigoid?, British Journal of Dermatology, vol.9, issue.2, pp.212-221, 2014.
DOI : 10.1111/j.1365-2230.1984.tb00860.x

L. Jan, S. Plée, J. Vallerand, D. Dupont, A. Delanez et al., Innate Immune Cell???Produced IL-17 Sustains Inflammation in Bullous Pemphigoid, Journal of Investigative Dermatology, vol.134, issue.12, pp.2908-2925, 2014.
DOI : 10.1038/jid.2014.263

M. Arakawa, T. Dainichi, N. Ishii, T. Hamada, T. Karashima et al., Lesional Th17 cells and regulatory T cells in bullous pemphigoid, Experimental Dermatology, vol.18, issue.12, 2011.
DOI : 10.1111/j.1600-0625.2006.00522.x

URL : http://onlinelibrary.wiley.com/doi/10.1111/j.1600-0625.2011.01378.x/pdf

D. Auria, L. , C. Fei, P. Ameglio, and F. , Cytokines and bullous pemphigoid, Eur Cytokine Netw, vol.10, pp.123-157, 1999.

D. Auria, L. Mussi, A. Bonifati, C. Mastroianni, A. Giacalone et al., Increased serum IL-6, TNF-alpha and IL-10 levels in patients with bullous pemphigoid: relationships with disease activity, Journal of the European Academy of Dermatology and Venereology, vol.298, issue.1, pp.11-16, 1999.
DOI : 10.1007/s004030050259

F. Ameglio, D. Auria, L. Bonifati, C. Ferraro, C. Mastroianni et al., Cytokine pattern in blister fluid and serum of patients with bullous pemphigoid: relationships with disease intensity, British Journal of Dermatology, vol.90, issue.4, pp.611-4533, 1998.
DOI : 10.1016/0167-5699(93)90230-I

M. Commin, E. Schmidt, S. Duvert-lehembre, A. Lasek, C. Morice et al., Clinical and immunological features and outcome of anti-p200 pemphigoid, British Journal of Dermatology, vol.34, issue.4, pp.776-81, 2016.
DOI : 10.1111/j.1346-8138.2007.00208.x

F. Antonicelli and R. Ludwig, New insights into pemphigoid diseases, Experimental Dermatology, vol.18, issue.12, pp.1151-1154, 2017.
DOI : 10.1111/j.1600-0625.2009.00934.x